Feedback / Questions
indatuximab ravtansine (BT-062) - ImmunoGen, ADMA Biologics
Biotest: H1 2014 Results
(Biotest)
-
Aug 16, 2014 -
Anticipated presentation of additional data from P2 trial for multipleim myeloma at ASH (Dec 06-Dec 09, 2014)
Anticipated P2 data
•
Multiple Myeloma • Oncology
http://www.biotest.de/ww/en/pub/investor_relations/publications/presentation.cfm
Aug 16, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.